Slides
Page 1
STEADY. STRONG. GROWING. Investor Presentation October 2026
Page 2
STEADY. STRONG. GROWING. Safe Harbor This presentation has been prepared by and is the sole responsibility of Sharda Cropchem Limited (the “Company”). By accessing this presentation, you are agreeing to be bound by the trailing restrictions. This presentation does not constitute or form part of any offer or invitation or inducement to sell or issue, or any solicitation of any offer or recommendation to purchase or subscribe for, any securities of the Company, nor shall it or any part of it or the fact of its distribution form the basis of, or be relied on in connection with, any contract or commitment thereof. In particular, this presentation is not intended to be a prospectus or offer document under the applicable laws of any jurisdiction, including India. No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the date of this presentation. There is no obligation to update, modify or amend this communication or to otherwise notify the recipient if the information, opinion, projection, forecast or estimate set forth herein, changes or subsequently becomes inaccurate. Certain statements contained in this presentation that are not statements of historical fact constitute “forward-looking statements.” You can generally identify forward looking statements by terminology such as “aim”, “anticipate”, “believe”, “continue”, “could”, “estimate”, “expect”, “intend”, “may”, “objective”, “goal”, “plan”, “potential”, “project”, “pursue”, “shall”, “should”, “will”, “would”, or other words or phrases of similar import. These forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors that may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements or other projections. Important factors that could cause actual results, performance or achievements to differ materially include, among others: (a) our ability to successfully implement our strategy, (b) our growth and expansion plans, (c) changes in regulatory norms applicable to the Company, (d) technological changes, (e) investment income, (f) cash flow projections, and (g) other risks. This presentation is for general information purposes only, without regard to any specific objectives, financial situations or informational needs of any particular person. The Company may alter, modify or otherwise change in any manner the content of this presentation, without obligation to notify any person of such change or changes. 2
Page 3
ADVANCING GLOBAL AGRICULTURE THROUGH AN IP-LED GROWTH PLATFORM Sharda Cropchem Limited is a leading intellectual property-driven agrochemical company engaged in the marketing and distribution of crop protection formulations and generic active ingredients. Supported by a growing portfolio of dossiers, registrations and intellectual property rights, SCL has built a differentiated platform for sustainable growth across regulated global markets, particularly in Europe, North America, Latin America and Morocco. 3
Page 4
CREATING VALUE THROUGH AN ASSET-LIGHT, REGISTRATION- LED BUSINESS MODEL SCL’s Core Capabilities Basic & Applied Research Product Identification Product Registration Active Ingredient Manufacturing Formulation & Packaging Marketing & Distribution √ √ √ √ (Partner Led) (Partner Led) SCL strategically participate in the stages where regulatory expertise, market knowledge and customer access create the greatest value, while leveraging specialized partners for manufacturing-related activities At the core of SCL business model is a growing portfolio of regulatory assets that facilitates access to some of the world’s most attractive crop protection markets. By partnering with specialized manufacturers for active ingredients, formulation and packaging, we remain capital efficient, operationally agile and well positioned to scale across geographies and product categories SCL’s position within the value chain enables the Company to retain control over registrations and customer relationships while benefiting from the flexibility and efficiency of a partner-led manufacturing network 4
Page 5
CREATING VALUE ACROSS THE CHAIN Identifying Opportunities Ahead of the Market Continuously monitor patent landscapes, crop trends and regulatory developments to identify generic molecules with strong commercial potential. By initiating registrations ahead of market opportunities, SCL creates a foundation for future growth and market access Value Created • Early entry into attractive product categories • Diversified product portfolio • Long-term revenue visibility • Sustainable growth opportunities Building Regulatory Assets through Dossier Development Working with accredited laboratories and technical experts, we develop strong dossiers aligned with jurisdiction-specific requirements. These registrations serve as valuable intellectual property assets and create meaningful barriers to entry Value Created • Long-term market access • Strong competitive differentiation • High entry barriers • Scalable registration portfolio Leveraging a Flexible Supply Network We source active ingredients through established supplier relationships, primarily from China, ensuring supply reliability, procurement flexibility and cost competitiveness Value Created • Resilient supply chain • Flexible procurement capabilities • Efficient cost structure • Responsive sourcing capabilities Commercializing Products at Global Scale Our products reach customers through a network of more than 525 distributors, supported by a sales force of over 500 professionals across key agricultural markets worldwide. This network also provides valuable market intelligence that supports portfolio expansion and customer engagement Value Created • Global market reach • Diversified revenue streams • Faster commercialization • Strong customer relationships 5
Page 6
ENSURING REACH THAT SERVES GLOBALLY Supported by a network of distributors and sales professionals, SCL serves customers across 80+ countries spanning Europe, North America, Latin America, Africa, and other international markets. This extensive presence not only expands the Company’s market reach but also enables to access specialized sales and local marketing talent across key agricultural regions. 80+ Countries 525+ Distributors 500+ Sales Professionals Rs. 419 Crs. Capex (H1 FY27) 3,044 Registrations SCL’s extensive global presence is complemented by a well-established network of third-party distributors. Together, these capabilities enable the effective commercialisation of formulations and generic active ingredients while strengthening customer engagement. SCL’s global footprint supports a factory-to-farmer approach, broadens revenue streams and enhances business resilience. Combined with local market expertise and strong channel partnerships, it provides a scalable platform for sustainable growth. 6
Page 7
STEADY. STRONG. GROWING. AGROCHEMICALS NON - AGROCHEMICAL Crop protection solutions that help improve yields and safeguard agricultural productivity across global markets. Agrochemicals remain our core business PRODUCT PORTFOLIO Leverages the same sourcing, logistics and distribution capabilities to serve a range of industrial applications — broadening our addressable market beyond agriculture. PRODUCT PORTFOLIO Herbicides Help control weeds and reduce competition for nutrients, water and sunlight, supporting healthier crop growth and improved yields Fungicides Protect crops from fungal diseases that can adversely impact productivity, quality and harvest outcomes Insecticides Safeguard crops against insect infestations, helping minimize crop losses and improve agricultural efficiency Biocides Specialized products supporting crop hygiene, protection and overall plant health across agricultural applications Rubber and Conveyor Belts Products serving material handling and heavy-duty industrial applications across sectors Dyes and Dye Intermediates Inputs catering to textile manufacturing and other industrial processing applications Industrial Chemicals Products supporting water treatment, food processing and other allied industries AGROCHEMICALS Two Business Segments, One Platform Common Foundation: Both segments are supported by a shared platform of global sourcing, registrations and distribution — an asset-light model that efficiently serves agricultural and industrial markets alike 7
Page 8
STEADY. STRONG. GROWING. Building on a period of strong progress, SCL is strengthening its platform for sustainable growth and long-term value creation — centred on regulatory expertise, market access, portfolio depth and customer proximity, while maintaining financial discipline and operational excellence Forward Integration — Building the Sales Force Strengthening market presence by moving closer to customers through a factory-to- farmer approach — enhanced commercial capabilities and deeper engagement to expand reach across key geographies. Expand and Strengthen Distribution Presence Leveraging SCL’s extensive dossier library and registrations to deepen penetration in existing markets while selectively entering new geographies, supporting broader access and sustainable growth. Continual Investment in Registrations Registrations remain a key pillar of SCL’s model. SCL will continue identifying attractive off-patent molecules, investing in dossier development and securing registrations in our own name. Focus on Operational Efficiencies Committed to improving productivity, optimising costs and prioritising revenue-generating investments — supporting margin expansion, strengthening competitiveness and enhancing overall performance. Supporting Priorities — Deepen Portfolio & Maintain Financial Discipline Expanding product relevance across markets and customer segments, while preserving balance sheet strength through prudent capital allocation and disciplined working capital management — together charting a clear roadmap for long-term growth. Building the Next Phase 8
Page 9
STEADY. STRONG. GROWING. IP-led Growth Model Strong portfolio of registrations, dossiers and IP rights supporting market access and long-term growth Capital-efficient model focused on identifying attractive generic molecules and registration opportunities Strong relationships with multiple manufacturers and formulators ensure reliable, competitive supply Operations spanning 80+ countries across Europe, North America, Latin America and other markets Widespread network of distributors and sales professionals across the agrochemical value chain Together, these strengths enable us to expand our global footprint, respond to evolving agricultural needs and create sustainable value for stakeholders. IP-led Growth Model Asset-Light Operations Global Presence Extensive Distribution Reach Diversified Sourcing Network The Sharda Advantage: A Differentiated Business Model 9
Page 10
STEADY. STRONG. GROWING. Mr. Ramprakash V. Bubna Chairman & Managing Director ✓ Holds a Bachelor’s Degree of Technology in Chemical Engineering from IIT, Bombay ✓ He has over 58 years of experience in chemicals, agrochemicals and related businesses ✓ He is responsible for the Company’s overall business operations and strategy Mr. Ashish Bubna Whole Time Director ✓ Holds a Bachelor’s Degree in Commerce from the University of Mumbai ✓ Over 35 years of experience in marketing of chemicals, agrochemicals and related businesses. ✓ Instrumental in strategizing early investment in product registrations and building the library of product dossiers. ✓ Responsible for marketing, procurement, registrations and logistics functions of the agrochemical business Mr. Manish Bubna Whole Time Director ✓ Holds a Bachelor’s Degree in Chemical Engineering from the Department of Chemical Technology, Bombay University. ✓ Over 33 years of experience in chemicals, agrochemicals and related businesses ✓ Spearheaded the Company’s foray into the conveyor belt and general chemicals business ✓ Also oversees the information technology, logistics and documentation functions of the Company Experienced Management 10
Page 11
Q2 FY27 Financial Highlights
Page 12
STEADY. STRONG. GROWING. Q2 FY27 Financial Highlights Revenue Agro-chemical Segment (A) Rs. 840 Crs. (+5% YoY) Revenue Non Agro-chemical Segment (B) Rs. 212 Crs. (+68% YoY) Total Revenue (A+B) Rs. 1,052 Crs. (+13% YoY) Gross Profit Rs. 378 Crs. (+18% YoY) EBITDA Rs. 164 Crs. (+18% YoY) EBITDA Margin 15.6% (+70 bps YoY) Profit Before Tax (PBT)* (*excl. Forex gains) Herbicides Insecticides Fungicides Product Wise Rs. 108 Crs. (+17% YoY) Rs. 432 Crs. (-1% YoY) Rs. 263 Crs. (+18% YoY) Rs. 144 Crs. (+2% YoY) On Consolidated Basis 12
Page 13
STEADY. STRONG. GROWING. Q2 FY27 Financial Highlights (Region Wise Breakup) Europe Rs. 429 Crs. (-7% YoY) NAFTA Rs. 227 Crs. (+6% YoY) LATAM Rs. 128 Crs. (+81% YoY) LATAM ROW Non – Agro Agro ROW Rs. 55 Crs. (0% YoY) Europe Rs. 29 Crs. (+16% YoY) NAFTA Rs. 152 Crs. (+94% YoY) Rs. 12 Crs. (+6% YoY) Rs. 19 Crs. (+59% YoY) 13
Page 14
H1 FY27 Financial Highlights
Page 15
STEADY. STRONG. GROWING. H1 FY27 Financial Highlights Revenue Agro-chemical Segment (A) Rs. 1,755 Crs. (+6% YoY) Revenue Non Agro-chemical Segment (B) Rs. 371 Crs. (+40% YoY) Total Revenue (A+B) Rs. 2,125 Crs. (+11% YoY) Gross Profit Rs. 772 Crs. (+15% YoY) EBITDA Rs. 343 Crs. (+22% YoY) EBITDA Margin 16.1% (+140 bps YoY) Profit Before Tax (PBT)* (*excl. Forex gains) Herbicides Insecticides Fungicides Product Wise Rs. 219 Crs. (+16% YoY) Rs. 890 Crs. (+4% YoY) Rs. 496 Crs. (+16% YoY) Rs. 369 Crs. (+2% YoY) 15 On Consolidated Basis
Page 16
STEADY. STRONG. GROWING. H1 FY27 Financial Highlights (Region Wise Breakup) Europe Rs. 896 Crs. (-9% YoY) NAFTA Rs. 567 Crs. (+21% YoY) LATAM Rs. 199 Crs. (+69% YoY) LATAM ROW Non – Agro Agro ROW Rs. 93 Crs. (+22% YoY) Europe Rs. 48 Crs. (+3% YoY) NAFTA Rs. 273 Crs. (+60% YoY) Rs. 17 Crs. (-28% YoY) Rs. 33 Crs. (+36% YoY) 16
Page 17
STEADY. STRONG. GROWING. Q2 & H1 FY27 Financial Highlights Particulars Q2 FY27 Q2 FY26 Y-o-Y H1 FY27 H1 FY26 Y-o-Y Revenue from Operations 1,051.7 929.1 +13% 2,125.5 1,913.9 +11% COGS 673.7 608.4 1353.5 1,244.0 Gross Profit 377.9 320.7 +18% 771.9 669.9 +15% Gross Margin % 35.9% 34.5% +140 bps 36.3% 35.0% +130 bps Employee Expenses 17.9 12.3 35.5 27.3 Other Expenses 195.6 169.5 393.5 361.5 EBITDA 164.5 138.9 +18% 342.9 281.1 +22% EBITDA Margin % 15.6% 15.0% +70 bps 16.1% 14.7% +140 bps Forex (Gain)/Loss 0.4 6.1 (7.2) (67.0) Depreciation & Amortisation 100.4 76.2 200.6 154.3 Other Income 44.6 29.4 79.2 61.9 EBIT 108.4 86.1 +26% 228.6 255.8 (11%) EBIT Margin % 10.3% 9.3% +100 bps 10.8% 13.4% (260) Bps Finance Cost 0.9 0.3 2.7 0.9 PBT* 107.5 85.7 +25% 225.9 254.9 (11%) Tax Expense 15.8 11.4 46.2 37.7 PAT* 91.7 74.4 +23% 179.7 217.2 (17%) PAT Margin % 8.7% 8.0% +70 bps 8.5% 11.3% (290) bps EPS (In Rs.) 10.2 8.2 19.9 24.1 17 On Consolidated Basis * Profit Before Tax & Profit After Tax growth was due to higher forex gains in H1FY26 Cr.
Page 18
STEADY. STRONG. GROWING. Balance Sheet EQUITY & LIABILITIES Sep-26 Mar-26 Equity Equity share capital 90.2 90.2 Other equity 3,159.8 3,046.3 Equity attributable to equity holders of the Company 3,250.0 3,136.5 Non-controlling interests 0.5 0.5 Total Equity 3,250.5 3,137.0 Non-current liabilities Financial liabilities Lease liabilities 15.2 - Other financial liabilities 20.5 35.4 Provisions 0.2 0.3 Deferred tax liabilities (net) 236.0 221.3 Total non-current liabilities 271.9 257.1 Current liabilities Financial liabilities Lease liabilities 9.1 - Trade payables total outstanding dues of micro enterprises and small enterprises 7.1 7.7 other than micro enterprises and small enterprises 1,431.1 1,491.0 Other financial liabilities 523.5 641.6 Other current liabilities 74.9 149.6 Provisions 85.9 90.4 Current tax liabilities (net) 5.1 6.0 Total current liabilities 2,136.7 2,386.2 Total Equity & Liabilities 5,659.1 5,780.3 ASSETS Sep-26 Mar-26 Non-current assets Property, plant and equipment 2.1 2.5 Right to use assets 23.7 - Intangible assets 1,059.3 986.2 Intangible assets under development 303.8 247.2 Financial assets Other Financial Assets 58.9 58.3 Deferred Tax Assets 31.4 23.6 Non-current tax assets (net) 17.2 3.3 Other non-current assets 12.0 21.0 Total non-current assets 1,508.4 1,342.2 Current assets Inventories 1,529.0 1,119.6 Financial assets Investments 362.9 361.4 Trade receivables 1,460.9 2,389.3 Cash and cash equivalents 299.0 219.8 Bank balance other than cash and cash equivalents 0.4 0.1 Other financial assets 191.2 130.5 Other current assets 307.4 217.4 Total current assets 4,150.8 4,438.1 Total Assets 5,659.1 5,780.3 Cr. 18 On Consolidated Basis
Page 19
STEADY. STRONG. GROWING. Cash Flow Statement Cr. Particulars Sep-26 Sep-25 Profit Before Tax 225.9 254.9 Adjustments 139.4 126.5 Operating profit before working capital changes 365.4 381.3 Changes in working capital 252.9 229.0 Cash generated from operations 618.2 610.3 Direct taxes paid (net of refund) (54.0) (5.2) Net Cash from Operating Activities 564.2 605.1 Net Cash from Investing Activities (405.8) (523.8) Net Cash from Financing Activities (88.1) (59.3) Exchange difference arising on conversion (debited) / credited to foreign currency translation reserve 14.9 11.9 Net Change in cash and cash equivalents 85.2 34.0 Opening Cash Balance 219.8 127.2 Effect of exchange rate changes on cash & cash equivalents held in foreign currencies (6.0) 4.1 Closing Cash Balance 299.0 165.3 19 On Consolidated Basis
Page 20
STEADY. STRONG. GROWING. TOTAL EQUITY ^ Rs. 3,250 Crs. vs Rs. 3,137 Crs. as on Mar’26 CASH, BANK & LIQUID INVESTMENTS ^ Rs. 846 Crs. vs Rs. 702 Crs. as on Mar’26 RETURNS* 26.0% RoCE 20.2% RoE WORKING CAPITAL (IN DAYS) 98 → 70 days Mar26 Sep’26 Reduced Working Capital by 28 days * RoCE = TTM EBIT / Average Capital Employed ; RoE = TTM PAT / Average Equity (As on 30 th Sep 2026) ^ As on 30th Sep 2026 72 98 151 90 125 118 Mar-26 Sep-26 Inventory Days Recievable Days Creditor Days Strong Balance Sheet 20 On Consolidated Basis
Page 21
Annexure
Page 22
STEADY. STRONG. GROWING. Key Financial Performance Indices Revenue EBITDA & EBITDA Margin* Profit After Tax & PAT Margin 3,580 4,045 3,163 4,320 5,268 FY22 FY23 FY24 FY25 FY26 729 713 318 613 1,040 FY22 FY23 FY24 FY25 FY26 349 342 32 304 681 FY22 FY23 FY24 FY25 FY26 RoCE RoE Cash, Bank & Liquid Investments^ FY22 FY23 FY24 FY25 FY26 25.7% 20.8% 3.4% 16.0% 30.4% 262 325 375 558 702 FY22 FY23 FY24 FY25 FY26FY22 FY23 FY24 FY25 FY26 19.8% 16.5% 1.4% 12.8% 24.2% ^ Total Cash & Cash Equivalents (Includes FDs clubbed in Non Current Other Financial Assets) 20.4% 17.6% 10.1% 14.2% 9.8% 8.5% 1.0% 7.0% * EBITDA is excluding IA & IAUD write-off Cr. 19.7% 12.9% 22 On Consolidated Basis
Page 23
STEADY. STRONG. GROWING. Historical Profit & Loss Particulars FY26 FY25 FY24 FY23 FY22 Revenue from Operations 5,267.6 4,319.9 3,163.0 4,045.2 3,579.8 COGS 3,377.2 3,028.1 2,342.4 2,860.8 2,499.8 Gross Profit 1,890.4 1,291.8 820.6 1,184.4 1,080.0 Gross Margin % 35.9% 29.9% 25.9% 29.3% 30.2% Employee Expenses 66.7 52.0 42.4 44.8 44.2 Other Expenses 784.2 626.3 494.9 438.9 336.4 EBITDA* 1,039.5 613.5 318.1 712.6 728.6 EBITDA Margin % 19.7% 14.2% 10.1% 17.6% 20.4% Forex (Gain)/Loss -36.7 17.9 0.4 57.6 16.5 Depreciation & Amortisation 324.5 274.7 267.1 248.1 245.3 Other Income 105.5 59.5 59.8 40.3 28.9 EBIT 857.3 380.4 75.5 435.3 466.5 EBIT Margin % 16.3% 8.8% 2.4% 10.8% 13.0% Finance Cost 1.8 2.1 3.6 4.5 2.2 PBT 855.5 378.3 71.9 430.7 464.2 Tax Expense 174.5 73.9 40.0 88.8 115.0 PAT 681.0 304.4 31.9 342.0 349.3 PAT Margin % 12.9% 7.0% 1.0% 8.5% 9.8% Earnings Per Share (EPS) In Rs. 75.48 33.74 3.53 37.90 38.71 Cr. * EBITDA is excluding IA & IAUD write-off 23 On Consolidated Basis
Page 24
STEADY. STRONG. GROWING. Balance Sheet – Equity & Liabilities Equities & Liabilities Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Shareholder's Funds Equity and Share Capital 90.2 90.2 90.2 90.2 90.2 Other Equity 3,046.3 2,410.3 2,146.9 2,141.8 1,822.2 Non-controlling Interest 0.5 0.4 0.4 0.4 0.3 Total Equity 3,137.0 2,501.0 2,237.5 2,232.4 1,912.8 Non-Current Liabilities Borrowings - - - - - Trade Payables - - - - 2.4 Lease Liabilities - - 7.8 - 3.5 Other Financial Liabilities 35.4 63.0 58.4 1.7 1.6 Provisions 0.3 1.3 1.4 2.7 2.3 Deferred Tax Liabilities (net) 221.3 173.8 152.8 143.4 128.9 Total Non-Current Liabilities 257.1 238.1 220.3 147.9 138.6 Current Liabilities Borrowings - - 3.4 3.0 38.0 Lease Liabilities - 7.8 7.2 - 5.1 Trade Payables 1,498.7 1,310.2 921.2 1,377.6 1,177.6 Other Financial Liabilities 641.6 501.3 502.5 431.4 324.8 Other Current Liabilities 149.6 104.7 69.0 78.1 55.4 Current Tax Liabiliies 6.0 4.2 1.5 19.1 4.2 Provisions 90.4 57.6 76.0 61.4 86.7 Total Current Liabilities 2,386.2 1,985.7 1,580.5 1,970.6 1,691.8 Total Equity & Liabilities 5,780.3 4,724.9 4,038.3 4,350.8 3,743.1 Cr. 24 On Consolidated Basis
Page 25
STEADY. STRONG. GROWING. Balance Sheet – Assets ASSETS Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Assets Non-Current Assets Property, Plant and Equipment 2.5 3.0 3.8 5.0 14.4 Right to Use Assets - 7.2 14.4 - - Goodwill - - - - - Other Intangible assets 986.2 740.2 690.0 663.0 577.4 Intangible assets under development 247.2 291.4 282.9 203.9 212.2 Deferred Tax Assets (net) 23.6 11.6 10.3 7.9 4.9 Non-Current Tax Assets 3.3 63.4 72.1 72.3 71.6 Other financial assets 58.3 5.4 5.3 120.7 11.2 Other Non Current Assets 21.0 16.4 21.7 19.9 - Total Non-Current Assets 1,342.2 1,138.5 1,100.4 1,092.7 891.7 Current Assets Inventories 1,119.6 971.9 991.6 1,134.3 892.8 Investments 361.4 294.3 158.9 31.9 134.4 Trade Receivables 2,389.3 1,955.4 1,498.0 1,833.3 1,540.0 Cash & Cash equivalents 219.8 127.2 87.3 176.4 56.7 Other Bank balances 0.1 93.1 0.6 0.2 109.3 Loans - - - - 0.5 Other Financial Assets 130.6 47.5 128.1 5.5 49.9 Other Current Assets 217.3 96.8 73.4 76.5 67.9 Total Current Assets 4,438.1 3,586.4 2,937.9 3,258.2 2,851.5 Total Assets 5,780.3 4,724.9 4,038.3 4,350.8 3,743.1 Cr. 25 On Consolidated Basis
Page 26
STEADY. STRONG. GROWING. Cash Flow Statement Cr. Particulars Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Profit Before Tax 855.5 378.3 71.9 430.7 464.2 Adjustments 319.1 286.8 272.8 266.5 256.9 Operating profit before working capital changes 1,174.6 665.1 344.6 697.2 721.1 Changes in working capital (453.9) (30.5) 47.0 (303.7) (379.2) Cash generated from operations 720.7 634.6 391.7 393.5 341.9 Direct taxes paid (net of refund) (65.0) (31.0) (50.4) (65.3) (74.8) Net Cash from Operating Activities 655.7 603.6 341.3 328.3 267.1 Net Cash from Investing Activities (513.1) (510.1) (393.5) (145.2) (207.9) Net Cash from Financing Activities (118.3) (67.9) (36.9) (97.1) (91.0) Exchange difference arising on conversion (debited) / credited to foreign currency translation reserve 63.3 14.3 0.6 33.0 2.8 Net Change in cash and cash equivalents 87.7 39.9 (88.5) 119.0 (28.9) Opening Cash Balance 127.2 87.3 176.4 56.7 85.6 Effect of exchange rate changes on cash & cash equivalents held in foreign currencies 4.9 (0.1) (0.5) 0.7 - Closing Cash Balance 219.8 127.2 87.3 176.4 56.7 26 On Consolidated Basis
Page 27
Company: Sharda Cropchem Limited CIN: L51909MH2004PLC145007 THANK YOU Mr. Shailesh Mehendale – CFO cfo@shardaintl.com / finance@shardaintl.com Tel: +91 22 6678 2800 Mr. Deven Dhruva / Mr. Ronak Jain deven.dhruva@sgapl.net / ronak.jain@sgapl.net Tel: +91 98333 73300 / +91 98209 50544 Investor Relation Advisors: Strategic Growth Advisors Pvt. Ltd. CIN: U74140MH2010PTC204285 STEADY. STRONG. GROWING.